XT
ENGN icon

XTX Topco’s enGene Therapeutics ENGN Stock Holding History

XTX Topco’s Portfolio ENGN Stock Details ENGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$637K Buy
93,496
+69,574
+291% +$619K 0.01% 1803
2025
Q4 		$216K Buy
+23,922
New +$192K 0.01% 2343

Other funds holding ENGN

FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

XTX Topco's ENGN Position: Q1 2026 in Review

XTX Topco increased its enGene Therapeutics (ENGN) stake by 291% in Q1 2026, buying an estimated $619K and bringing the position to 93,496 shares worth $637K. The position accounts for 0.01% of the portfolio, ranked #1803.

XTX Topco first reported a position in ENGN in Q4 2025 and has held it in 2 quarters since. 61 funds tracked by Wall St. Rank hold ENGN as of Q1 2026.

  • XTX Topco held 93,496 shares of enGene Therapeutics worth $637K as of Q1 2026.
  • XTX Topco bought 69,574 enGene Therapeutics shares in Q1 2026, an estimated $619K.
  • enGene Therapeutics made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1803 holding.
  • XTX Topco first reported a position in enGene Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 61 funds tracked by Wall St. Rank held enGene Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.